{"id":45,"date":"2017-03-15T08:33:33","date_gmt":"2017-03-14T23:33:33","guid":{"rendered":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/?page_id=45"},"modified":"2022-11-10T09:58:51","modified_gmt":"2022-11-10T00:58:51","slug":"2016%e5%b9%b4","status":"publish","type":"page","link":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/works\/2016%e5%b9%b4\/","title":{"rendered":"2016"},"content":{"rendered":"

\u539f\u8457\u8ad6\u6587<\/strong><\/p>\n

    \n
  1. Onishi J, Sato Y, Sawaguchi A, Yamashita A, Maekawa K, Sameshima H, Asada Y. Stratified mucin-producing intraepithelial lesion with invasive carcinoma: 12 cases with immunohistochemical and ultrastructural findings. Hum Pathol. 2016;55:174-81.<\/li>\n
  2. Furukoji E, Gi T, Yamashita A, Moriguchi-Goto A, Kojima M, Sugita C, Sakae T, Sato Y, Hirai T, Asada Y. CD163 macrophage and erythrocyte contents in aspirated deep vein thrombus are associated with the time after onset: a pilot study. Thromb J. 2016:14:46<\/li>\n
  3. Shishikura K, Horiuchi T, Sakata N, Trinh DA, Shirakawa R, Kimura T, Asada Y, Horiuchi H. Prostaglandin E(2) inhibits neutrophil extracellular trap formation through production of cyclic AMP. Br J Pharmacol. 2016;173:319-31<\/li>\n
  4. Hao Y, Tsuruda T, Sekita-Hatakeyama Y, Kurogi S, Kubo K, Sakamoto S, Nakamura, Udagawa N, Sekimoto T, Hatakeyama K, Chosa E, Asada Y, Kitamura K. Cardiac hypertrophy is exacerbated in aged mice lacking the osteoprotegerin gene. Cardiovasc Res. 2016;110:62-72.<\/li>\n
  5. Tsuruda T, Sekita-Hatakeyama Y, Hao Y, Sakamoto S, Kurogi S, Nakamura M, Udagawa N, Funamoto T, Sekimoto T, Hatakeyama K, Chosa E, Kato J, Asada Y, Kitamura K. Angiotensin II stimulation of cardiac hypertrophy and functional decompensation in osteoprotegerin-deficient mice. Hypertension. 2016;67:848-56.<\/li>\n
  6. Yamamoto H, Yoshida A, Taguchi K, Kohashi K, Hatanaka Y, Yamashita A, Mori D, Oda Y. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Histopathology. 2016;69:72-83.<\/li>\n
  7. Tokumitsu T, Sato Y, Yamashita A, Moriguchi-Goto S, Kondo K, Nanashima A, Asada Y. Immunocytochemistry for Claudin-18 and Maspin in biliary brushing cytology increases the accuracy of diagnosing pancreatobiliary malignancies. Cytopathology. 2016 (In press).<\/li>\n
  8. Konishi Y, Satoh H, Kuroiwa Y, Kusaka M, Yamashita A, Asada Y, Asanuma T. Application of fiber tractography and diffusion tensor imaging to evaluate spinal cord diseases in dogs. J Vet Med Sci. 2016 (In press).<\/li>\n
  9. Yamada S, Koike T, Nakagawa T, Kuniyoshi N, Ying Y, Itabe H, Yamashita A, Asada Y, Shiomi M. Morphological features of coronary plaques in WHHLMI rabbits (Oryctolagus cuniculus), an animal model for familial hypercholesterolemia. Exp Anim. 2016 (In press).<\/li>\n
  10. Gi T, Sato Y, Tokumitsu T, Yamashita A, Moriguchi-Goto S, Takeshima H, Sato S, Asada Y. Microvascular proliferation of brain metastases mimics glioblastomas in squash cytology. Cytopathology. 2016 (In press).<\/li>\n<\/ol>\n

    \u75c7\u4f8b\u5831\u544a<\/strong><\/p>\n

      \n
    1. Kuroiwa Y, Aburaya M, Yamashita A, Miyati T, Shiiba T, Maeda M, Kihara Y, Asada Y, Imamura T. Diffusion-weighted MR Imaging of Deep Vein Thrombosis. Magn Reson Med Sci. 2016;15:144-5.<\/li>\n
    2. Ohno A, Sato Y, Nakamura E, Noguchi H, Tokumitsu T, Hiyoshi M, Nanashima A, Asada Y. Cytological findings and BCL10 expression in pancreatic acinar cell carcinoma: A Case Report. Diagn Cytopathol. 2016 (In press)<\/li>\n
    3. \u843d\u5408\u5f70\u5b50\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u7530\u4e2d\u5f18\u4e4b\u3001\u76db\u53e3\u6e05\u9999\u3001\u6cb3\u91ce\u5178\u5b50\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u798f\u5cf6\u548c\u5b50\u3001\u5927\u897f\u6df3\u4ec1\u3001\u9bab\u5cf6\u6d69\u3001\u6d45\u7530\u7950\u58eb\u90ce.\u3000\u5b50\u5bae\u981a\u90e8\u7d68\u6bdb\u817a\u7ba1\u72b6\u817a\u764c\u306bStratified mucin-producing intraepithelial lesion (SMILE)\u3092\u4f34\u3063\u305f1\u4f8b. \u8a3a\u65ad\u75c5\u7406 2016;35:66-6<\/li>\n
    4. \u9b4f\u3000\u5cfb\u6d38\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u6751\u5ca1\u7d14\u8f14\u3001\u798f\u5cf6\u548c\u5b50\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u9bab\u5cf6\u6d69\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u60aa\u6027\u5ea6\u306e\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u60aa\u6027Brenner\u816b\u760d\u306e1\u4f8b.\u3000\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u8a8c 2016; 7 : 17-19.
      \n\u9ed2\u6728\u6804\u8f1d\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u5cf0\u677e\u6620\u5b50\u3001\u5927\u91ce\u62db\u4f38\u3001\u6728\u7530\u548c\u8cb4\u3001\u8cc0\u5143\u654f\u884c\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u4f50\u85e4\u52c7\u4e00\u90ce. \u5c3f\u7d30\u80de\u8a3a\u3067\u5224\u5b9a\u306b\u82e6\u616e\u3057\u305f\u8180\u80f1\u816b\u760d\u306e1\u4f8b. \u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u4e5d\u5dde\u9023\u5408\u4f1a\u96d1\u8a8c 2016; 47: 65-68.<\/li>\n
    5. Moritake H, Takagi M, Kinoshita M, Ohara O, Yamamoto S, Moriguchi S, Nunoi H. Autoimmunity Including Intestinal Beh\u00e7et Disease Bearing the KRAS Mutation in Lymphocytes: A Case Report. Pediatrics. 2016;137:e20152891.<\/span><\/li>\n
    6. \n
      \u5927\u6817\u4f38\u884c\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u677e\u6fa4\u8061\u53f2\u3001\u798f\u5cf6\u548c\u5b50\u3001\u9bab\u5cf6\u6d69\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff0e<\/span>\u5b50\u5bae\u5e83\u9593\u819c\u5185\u306b\u751f\u3058\u305fSolitary Fibrous Tumor\u306e1\u4f8b\uff0e\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a\u8a8c\u00a0 \u00a02016; 7: 51-53<\/span><\/div>\n<\/li>\n<\/ol>\n

      \u8457\u66f8<\/strong><\/p>\n

        \n
      1. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u975e\u598a\u5a20\u6027\u7d68\u6bdb\u764c\u3001pp302-304 (2016)\u3000\u5375\u5de3, \u5375\u7ba1\u816b\u760d\u75c5\u7406\u30a2\u30c8\u30e9\u30b9\u3000\u6539\u5b9a\u30fb\u6539\u984c\u7b2c2\u7248\u3000(\u68ee\u8c37\u5353\u4e5f\u7de8)\u3001\u6587\u5149\u5802\u3001\u6771\u4eac<\/li>\n<\/ol>\n

        \u7dcf\u8aac<\/strong><\/p>\n

          \n
        1. Kuroiwa Y, Yamashita A, Imamura T, Asada Y. Magnetic resonance imaging for qualitative assessment of deep vein thrombosis. Med Imag & Info Sci. 2015; 32: 100-102.<\/li>\n
        2. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u51a0\u52d5\u8108\u75be\u60a3\u306e\u75c5\u614b\u3068\u8840\u6813\u306e\u5bc4\u4e0e\u3001\u5faa\u74b0\u5668\u5185\u79d12016; 79 (1): 7-12.<\/li>\n
        3. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u3068\u708e\u75c7\u7d30\u80de\u3001\u65e5\u672c\u81e8\u5e8a\u5897\u520a\u53f7\u6700\u65b0\u51a0\u52d5\u8108\u75be\u60a3\u5b662016; 74 (S4): 88-93.<\/li>\n
        4. \u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u8840\u6813\u5f62\u6210\u306e\u75c5\u7406\u5b66\u7684\u6a5f\u5e8f\u3001\u533b\u5b66\u306e\u3042\u3086\u307f. 2016; 257 (7): 741-747.<\/li>\n<\/ol>\n

          \u5b66\u4f1a\u767a\u8868<\/strong><\/p>\n

            \n
          1. \u6749\u7530\u5343\u6cf0\u3001\u4f50\u85e4\u5b54\u7f8e\u4e43\u3001\u5bae\u8def\u3000\u7fd4\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u5824\u3000\u91cd\u654f\u3001\u5409\u7530\u88d5\u6a39\u3001\u6e21\u8fba\u3000\u6e21\u3001\u5c71\u672c\u9686\u4e00\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u9ed2\u5ddd\u660c\u5f66. \u30d6\u30e9\u30b8\u30eb\u7523\u30d7\u30ed\u30dd\u30ea\u30b9\uff08AF-08\uff09\u306f\u30b3\u30e9\u30fc\u30b2\u30f3\u523a\u6fc0\u306b\u3088\u308b\u8840\u5c0f\u677f\u51dd\u96c6\u3092\u6291\u5236\u3059\u308b. \u65e5\u672c\u85ac\u5b66\u4f1a\u7b2c136\u5e74\u4f1a\uff08\u6a2a\u6d5c\u5e02\u30013\/26-29, 2016\uff09<\/li>\n
          2. Kuroiwa Y, Yamashita A, Nakamura E, Miyati T, Fukumi A, Fukuda A, Maeda M, Kihara Y, Imamura T and Asada Y.: Low and Iso-Signal Intensities in T2 and T1 Weighted Images in Deep Vein Thrombus Reflect Organizing Reaction. \u7b2c72\u56de\u65e5\u672c\u653e\u5c04\u7dda\u6280\u8853\u5b66\u4f1a\u7dcf\u4f1a\u5b66\u8853\u5927\u4f1a (\u6a2a\u6d5c\u5e02, 4\/14-17, 2016)<\/li>\n
          3. Maekawa K, Yamashita A, Nakamura E, Asada Y. Hypoxia in coronary plaque enhances thrombogenic potential in activated macrophages. ATVB\/PVD2016 (Nashville, 5\/4-6, 2016)<\/li>\n
          4. Yamashita A, Sugita C, Moriguchi-Goto S, Nakamura E, Maekawa K, Asada Y. Metabolites reflecting fresh venous thrombus: Lactic acid and guanine enhance whole blood coagulation. ATVB\/PVD2016 (Nashville, 5\/4-6, 2016)<\/li>\n
          5. Yamashita A, Furukoji E, Moriguchi-Goto S, Kojima M, Sugita C, Sato Y, Asada Y. CD163 macrophage content and glucose transporter-1 expression in aspirated deep vein thrombus are associated with the time after onset. ATVB\/PVD2016 (Nashville, 5\/4-6, 2016)<\/li>\n
          6. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u76db\u53e3\u6e05\u9999\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u798f\u5cf6\u525b\u3001\u9bab\u5cf6\u76f4\u6a39\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u6d45\u7530\u7950\u58eb\u90ce.\u8ee2\u79fb\u6027\u8133\u816b\u760d\u306b\u304a\u3051\u308b\u816b\u760d\u8840\u7ba1\u306e\u5f62\u614b\u5b66\u7684\u691c\u8a0e. \u7b2c105\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a (\u4ed9\u53f0\u5e02\u30015\/12-14, 2016)<\/li>\n
          7. \u4e2d\u6751\u6075\u7406\u5b50\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u76db\u53e3\u6e05\u9999\u3001\u9bab\u5cf6\u76f4\u6a39\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u5e73\u6238\u7d14\u5b50. \u4e0a\u76ae\u82bd\u7a2e\u6027\u30ed\u30bc\u30c3\u30c8\u3092\u4f34\u3063\u305fAtypical teratoid\/Rhabdoid tumor\u306e1\u4f8b. \u7b2c105\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a (\u4ed9\u53f0\u5e02\u30015\/12-14, 2016)<\/li>\n
          8. \u524d\u5ddd\u548c\u4e5f\u3001\u9b3c\u585a\u4e45\u5145\u3001\u576a\u5185\u62e1\u4f38\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u9bab\u5cf6\u76f4\u6a39\u3001\u76db\u53e3\u6e05\u9999\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u9b4f\u5cfb\u6d38\u3001\u6d45\u7530\u7950\u58eb\u90ce. Pulmonary capillary hemaniomatosis (PCH)\u306e1\u4f8b. \u7b2c105\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a (\u4ed9\u53f0\u5e02\u30015\/12-14, 2016)<\/li>\n
          9. \u798f\u898b\u30a2\u30a6\u30a7\u30a4\u30b9\uff0c\u9ed2\u5ca9\u3000\u9756\u6df3\uff0c\u5c71\u4e0b\u3000\u7be4\uff0c\u6d45\u7530\u7950\u58eb\u90ce. \u6838\u78c1\u6c17\u5171\u9cf4\u753b\u50cf\u306b\u3088\u308b\u6df1\u90e8\u9759\u8108\u8840\u6813\u306e\u5668\u8cea\u5316\u6240\u898b\uff1a\u75c5\u7406\u7d44\u7e54\u50cf\u3068\u306e\u5bfe\u6bd4. \u7b2c105\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a (\u4ed9\u53f0\u5e02\u30015\/12-14, 2016)<\/li>\n
          10. \u5c71\u5143\u82f1\u5d07\u3001\u5409\u7530\u6717\u5f66\u3001\u7530\u53e3\u5065\u4e00\u3001\u5b5d\u6a4b\u8ce2\u4e00\u3001\u7551\u4e2d\u512a\u8863\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u68ee\u3000\u5927\u8f14\u3001\u5c0f\u7530\u7fa9\u76f4. \u708e\u75c7\u6027\u7b4b\u7dda\u7dad\u82bd\u7d30\u80de\u816b\u760d\u306b\u304a\u3051\u308bALK, ROS1, NTRK3\u907a\u4f1d\u5b50\u518d\u69cb\u6210. \u7b2c105\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u7dcf\u4f1a (\u4ed9\u53f0\u5e02\u30015\/12-14, 2016)<\/li>\n
          11. \u5927\u6817\u4f38\u884c\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u677e\u6fa4\u8061\u53f2\u3001\u798f\u5cf6\u548c\u5b50\u3001\u9bab\u5cf6\u3000\u6d69\u3001\u6d45\u7530\u7950\u58eb\u90ce.\u3000\u5b50\u5bae\u5e83\u9593\u819c\u306b\u751f\u3058\u305fSolitary fibour tumor\u306e1\u4f8b. \u7b2c44\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a (\u6771\u4eac\u30016\/11, 2016)<\/li>\n
          12. \u5c71\u4e0b\u3000\u7be4\u3001\u53e4\u5c0f\u8def\u82f1\u4e8c\u3001\u76db\u53e3\u6e05\u9999\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u5e73\u4e95\u4fca\u7bc4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u6df1\u90e8\u9759\u8108\u8840\u6813\u306eCD163\u967d\u6027\u7d30\u80de\u6570\u3084\u30b0\u30eb\u30b3\u30fc\u30b9\u8f38\u9001\u4f531\u306e\u767a\u73fe\u306f\u767a\u75c7\u304b\u3089\u306e\u7d4c\u904e\u6642\u9593\u306b\u95a2\u9023\u3059\u308b. \u7b2c38\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u5948\u826f\u5e02\u30016\/8-10, 2016\uff09<\/li>\n
          13. \u9ed2\u5ca9\u9756\u6df3\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u4e2d\u6751\u3000\u6075\u7406\u5b50\u3001\u5bae\u5730\u3000\u5229\u660e\u3001\u798f\u898b\u3000\u30a2\u30a6\u30a7\u30a4\u30b9\u3001\u798f\u7530\u3000\u3055\u3068\u307f\u3001\u524d\u7530\u3000\u660c\u4e8c\u3001\u6728\u539f\u3000\u5eb7\u3001\u4eca\u6751\u3000\u5353\u90ce\u3001\u6d45\u7530\u3000\u7950\u58eb\u90ce\uff1aMRI discriminates organized from non-organized area in deep vein thrombus. \u7b2c38\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\uff08\u5948\u826f\u5e02\u30016\/16-18\uff0c2016\uff09<\/li>\n
          14. \u524d\u5ddd\u548c\u4e5f\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u4f4e\u9178\u7d20\u74b0\u5883\u3068\u708e\u75c7\u6027\u523a\u6fc0\u304c\u76f8\u52a0\u7684\u306b\u52d5\u8108\u786c\u5316\u5de3\u306e\u8840\u6813\u6027\u3092\u9ad8\u3081\u308b. \u7b2c4\u56de\u4f4e\u9178\u7d20\u7814\u7a76\u4f1a\uff08\u6771\u4eac\u30017\/23, 2016\uff09<\/li>\n
          15. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u76db\u53e3\u6e05\u9999\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u6d45\u7530\u7950\u58eb\u90ceStratified mucin-producing intraepithelial lesion (SMILE) 12\u4f8b\u306e\u81e8\u5e8a\u75c5\u7406\u5b66\u7684\u691c\u8a0e. \u7b2c13\u56de\u65e5\u672c\u75c5\u7406\u5b66\u4f1a\u30ab\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9 (\u795e\u6238\u5e02\u30017\/29, 2016)<\/li>\n
          16. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u798f\u5cf6\u3000\u525b\u3001\u677e\u5143\u6587\u5b5d\u3001\u7af9\u5cf6\u79c0\u96c4\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3000\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305fAtypical teratoid \/ rhabdoid tumor\u306e2\u4f8b. \u7b2c36\u56de\u65e5\u672c\u5c0f\u5150\u75c5\u7406\u7814\u7a76\u4f1a\u5b66\u8853\u96c6\u4f1a\uff08\u798f\u5ca1\u5e02\u30018\/27, 2016\uff09<\/li>\n
          17. \u5927\u91ce\u62db\u4f38\u3001\u91ce\u53e3\u88d5\u53f2\u3001\u5fb3\u6e80\u8cb4\u5b50\u3001\u795e\u7530\u4fee\u53f8\u3001\u5cf0\u677e\u6620\u5b50\u3001\u68ee\u7530\u52dd\u4ee3\u3001\u9ed2\u6728\u6804\u8f1d\u3001\u897f\u5ddd\u8a69\u7e54\u3001\u65ed\u5409\u96c5\u79c0\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\u3000\u8d85\u97f3\u6ce2\u5185\u8996\u93e1\u4e0b\u7a7f\u523a\u5438\u5f15\u7d30\u80de\u8a3a\u3067\u8a3a\u65ad\u306b\u82e6\u616e\u3057\u305f\u81b5\u817a\u623f\u7d30\u80de\u764c\u306e\uff11\u4f8b\uff0e\u7b2c23\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u4e5d\u5dde\u9023\u5408\u4f1a\u5b66\u4f1a\u3000(\u4e45\u7559\u7c73\u5e02\u30017\/23-24, 2016)<\/li>\n
          18. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u5a66\u4eba\u79d1\u5b50\u5bae\u5185\u819c\u7d30\u80de\u8a3a. \u75c5\u7406\u30fb\u7d30\u80de\u8a3a\u30bb\u30df\u30ca\u30fc. \u7b2c32\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u4e5d\u5dde\u9023\u5408\u4f1a\u3000(\u4e45\u7559\u7c73\u5e02\u30017\/23-24, 2016)<\/li>\n
          19. \u5c71\u4e0b\u3000\u7be4\u3001\u677e\u6d66\u7950\u4e4b\u4ecb\u3001\u8d99\u3000\u677e\u5409\u3001\u8d8a\u672c\u77e5\u5927\u3001\u4e45\u4e0b\u88d5\u53f8\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u7cd6\u5c3f\u75c5\u52d5\u8108\u786c\u5316\u8840\u7ba1\u306e\u4ee3\u8b1d\u3068\u4f4e\u9178\u7d20\u3068\u306e\u95a2\u9023. \u7b2c4\u56de\u30a6\u30b5\u30ae\u30d0\u30a4\u30aa\u30b5\u30a4\u30a8\u30f3\u30b9\u7814\u7a76\u4f1a\uff08\u4f50\u8cc0\u5e02\u30018\/6, 2016\uff09<\/li>\n
          20. \u6749\u7530\u5343\u6cf0\u3001\u4f50\u85e4\u5b54\u7f8e\u4e43\u3001\u5bae\u8def\u3000\u7fd4\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u5824\u3000\u91cd\u654f\u3001\u5409\u7530\u88d5\u6a39\u3001\u6e21\u8fba\u3000\u6e21\u3001\u5c71\u672c\u9686\u4e00\u3001\u6d45\u7530\u7950\u58eb\u90ce\u3001\u9ed2\u5ddd\u660c\u5f66. \u7b2c33\u56de\u548c\u6f22\u533b\u85ac\u5b66\u4f1a\u5b66\u8853\u5927\u4f1a\uff08\u6771\u4eac\u30018\/27-28, 2016\uff09<\/li>\n
          21. \u524d\u5ddd\u548c\u4e5f\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u6d45\u7530\u7950\u58eb\u90ce. \u51a0\u52d5\u8108\u30d7\u30e9\u30fc\u30af\u306e\u8840\u6813\u5f62\u6210\u6027\u306e\u691c\u8a0e\u300c\u4f4e\u9178\u7d20\u3068\u708e\u75c7\u306e\u76f8\u4e57\u52b9\u679c\u300d. \u7b2c21\u56de\u65e5\u672c\u8840\u7ba1\u75c5\u7406\u7814\u7a76\u4f1a\uff08\u6771\u4eac\u300110\/22\u30012016\uff09<\/li>\n
          22. \u5fb3\u6e80\u8cb4\u5b50\uff0c\u91ce\u53e3\u88d5\u53f2\uff0c\u5927\u91ce\u62db\u4f38\uff0c\u5cf0\u677e\u6620\u5b50\uff0c\u68ee\u7530\u52dd\u4ee3\uff0c\u9ed2\u6728\u6804\u8f1d\uff0c\u798f\u5cf6\u525b\u3001 \u76db\u53e3\u6e05\u9999\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\uff1aAtypical teratoid\/rhabdoid tumor\u306e2\u4f8b. \u7b2c55\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a\uff08\u5225\u5e9c\u5e02\u300111\/18-19, 2016\uff09<\/li>\n
          23. \u91ce\u53e3\u88d5\u53f2\uff0c\u5fb3\u6e80\u8cb4\u5b50\uff0c\u5927\u91ce\u62db\u4f38\uff0c\u5cf0\u677e\u6620\u5b50\uff0c\u68ee\u7530\u52dd\u4ee3\uff0c\u9ed2\u6728\u6804\u8f1d\uff0c\u76db\u53e3\u6e05\u9999\u3001\u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u773c\u4ed8\u5c5e\u5668\u306b\u767a\u751f\u3057\u305f\u4f4e\u60aa\u6027\u5ea6B\u7d30\u80de\u6027\u30ea\u30f3\u30d1\u816b\u306e4\u75c7\u4f8b. \u7b2c55\u56de\u65e5\u672c\u81e8\u5e8a\u7d30\u80de\u5b66\u4f1a\u79cb\u5b63\u5927\u4f1a\uff08\u5225\u5e9c\u5e02\u300111\/18-19, 2016\uff09<\/li>\n
          24. \u4e2d\u5c3e\u5927\u4f38\u3001\u6cb3\u91ce\u6587\u5f70\u3001\u7530\u4ee3\u8015\u76db\u3001\u68ee\u6d69\u8cb4\u3001\u7dd2\u65b9\u7965\u543e\u3001\u4f0a\u85e4\u6b4c\u7e54\u3001\u5e02\u6210\u76f4\u6a39\u3001\u6b66\u91ce\u614e\u7950\u3001\u6c60\u7530\u62d3\u4eba\u3001\u4e03\u5cf6\u7be4\u5fd7\u3001\u4e2d\u6751\u90fd\u82f1\u3001\u5f8c\u85e4\u6df8\u9999\u3001\u4f50\u85e4\u52c7\u4e00\u90ce. \u795e\u7d4c\u5185\u5206\u6ccc\u7d30\u80de\u764c\u6210\u5206\u3092\u4f34\u3063\u305f\u80c3\u817a\u764c\u306e1\u5207\u9664\u4f8b. \u7b2c78\u56de\u65e5\u672c\u81e8\u5e8a\u5916\u79d1\u5b66\u4f1a\u7dcf\u4f1a \uff08\u6771\u4eac\u300111\/24-26, 2016)<\/li>\n
          25. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u76db\u53e3\u6e05\u9999\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u9bab\u5cf6\u6d69\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u771f\u6027\u7652\u7740\u80ce\u76e4(Placenta accrete\u3000vera)\u306e\u81e8\u5e8a\u75c5\u7406\u5b66\u7684\u691c\u8a0e. \u7b2c24\u56de\u65e5\u672c\u80ce\u76e4\u5b66\u4f1a (\u548c\u6b4c\u5c71\u5e02\u300111\/25-26, 2016)<\/li>\n
          26. \u4f50\u85e4\u52c7\u4e00\u90ce\u3001\u76db\u53e3\u6e05\u9999\u3001\u5c71\u4e0b\u3000\u7be4\u3001\u524d\u5ddd\u548c\u4e5f\u3001\u4e2d\u6751\u6075\u7406\u5b50\u3001\u9b4f\u3000\u5cfb\u6d38\u3001\u798f\u5cf6\u548c\u5b50\u3001\u5927\u897f\u6df3\u4ec1\u3001\u5ddd\u8d8a\u9756\u4e4b\u3001\u9bab\u5cf6\u3000\u6d69\u3001\u6d45\u7530\u7950\u58eb\u90ce\uff1a\u5b50\u5bae\u4f53\u4e0b\u90e8\u306b\u767a\u751f\u3057\u305f\u985e\u5185\u819c\u817a\u764c\u306e1\u4f8b. \u7b2c45\u56de\u65e5\u672c\u5a66\u4eba\u79d1\u75c5\u7406\u5b66\u4f1a(\u938c\u5009\u5e02\u300112\/3, 2016)<\/li>\n<\/ol>\n

            \u30b7\u30f3\u30dd\u30b8\u30a6\u30e0<\/strong><\/p>\n

              \n
            1. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u8840\u7ba1\u75c5\u7406\u304b\u3089\u307f\u305f\u8840\u6813\u5f62\u6210\u3001\u7b2c41\u56de\u65e5\u672c\u8133\u5352\u4e2d\u5b66\u4f1a (\u672d\u5e4c\u5e02\u30014\/15, 2016)<\/li>\n
            2. \u5c71\u4e0b\u3000\u7be4\uff1a\u52d5\u8108\u786c\u5316\u6027\u8840\u6813\u30e2\u30c7\u30eb\u3092\u7528\u3044\u305f\u75c5\u614b\u89e3\u6790\uff1a\u30d7\u30e9\u30fc\u30af\u306e\u4f4e\u9178\u7d20\u3068\u8840\u6813\u5f62\u6210\u306e\u95a2\u9023\u3001\u7b2c48\u56de\u65e5\u672c\u52d5\u8108\u786c\u5316\u5b66\u4f1a\u7dcf\u4f1a\uff08\u6771\u4eac 7\/14-15, 2016\uff09<\/li>\n<\/ol>\n

              \u6559\u80b2\u8b1b\u6f14<\/strong><\/p>\n

                \n
              1. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u30d7\u30e9\u30fc\u30af\u7834\u7dbb\u3068\u8840\u6813\u5f62\u6210\u3001\u7b2c16\u56de\u52d5\u8108\u786c\u5316\u6559\u80b2\u30d5\u30a9\u30fc\u30e9\u30e0 (\u6771\u4eac\u30012\/7, 2016)<\/li>\n
              2. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u52d5\u8108\u786c\u5316\u6027\u30d7\u30e9\u30fc\u30af\u306e\u7834\u7dbb\u3068\u8840\u6813\u5f62\u6210\u3001\u7b2c38\u56de\u65e5\u672c\u8840\u6813\u6b62\u8840\u5b66\u4f1a\u5b66\u8853\u96c6\u4f1a\u3000(\u5948\u826f\u5e02\u30016\/17, 2016)<\/li>\n<\/ol>\n

                \u53d7\u8cde<\/strong><\/p>\n

                  \n
                1. \u5c71\u4e0b\u3000\u7be4\uff1a\u7b2c4\u56de\u30a6\u30b5\u30ae\u30d0\u30a4\u30aa\u30b5\u30a4\u30a8\u30f3\u30b9\u7814\u7a76\u4f1a\u3000\u512a\u79c0\u767a\u8868\u8cde<\/li>\n<\/ol>\n

                  \u30b9\u30e9\u30a4\u30c9\u30b3\u30f3\u30d5\u30a1\u30ec\u30f3\u30b9<\/strong><\/p>\n

                    \n
                  1. \u9b4f\u3000\u5cfb\u6d38\uff1a\u4e73\u623f\u4e73\u982d\u90e8\u816b\u760d (Solid papillary carcinoma in situ of nipple). \u7b2c351\u56de\uff08\u4e5d\u5dde\u5927\u5b66\u75c5\u9662\u3001\u798f\u5ca1\u5e02\uff09<\/li>\n
                  2. \u4e2d\u6751\u6075\u7406\u5b50\uff1a\u5185\u8033\u816b\u760d (Endolymphatic sac tumor)\u3000 \u7b2c352\u56de\uff08\u9e7f\u5150\u5cf6\u5e02\u7acb\u75c5\u9662\u3001\u9e7f\u5150\u5cf6\u5e02\uff09<\/li>\n
                  3. \u524d\u5ddd\u548c\u4e5f\uff1a\u80ba\u75c5\u5909(Pulmonary capillary hemangiomatosis)\u3001\u7b2c352\u56de\uff08\u9e7f\u5150\u5cf6\u5e02\u7acb\u75c5\u9662\u3001\u9e7f\u5150\u5cf6\u5e02\uff09<\/li>\n
                  4. \u524d\u5ddd\u548c\u4e5f\uff1a\u4e2d\u54bd\u982d\u816b\u760d\uff08Stratified ciliated papillary carcinoma, HPV-associated\uff09\u3001\u7b2c353\u56de\uff08\u4e5d\u5dde\u304c\u3093\u30bb\u30f3\u30bf\u30fc\u3001\u798f\u5ca1\u5e02\uff09<\/li>\n
                  5. \u4e2d\u6751\u6075\u7406\u5b50\uff1a\u814e\u816b\u760d\u3000(juxtaglomerular cell tumor) \u7b2c354\u56de\uff08\u770c\u7acb\u65e5\u5357\u75c5\u9662\u3001\u65e5\u5357\u5e02\uff09<\/li>\n<\/ol>\n

                    \u7814\u7a76\u52a9\u6210\u91d1<\/strong><\/p>\n

                      \n
                    1. \u6d45\u7530\u7950\u58eb\u90ce\uff1a\u79d1\u7814\u8cbb\u57fa\u76e4\u7814\u7a76B \u00a0\u75c5\u7406\u7d44\u7e54\u5b66\u3001\u7db2\u7f85\u7684\u4ee3\u8b1d\u89e3\u6790\u3001\u30ec\u30aa\u30ed\u30b8\u30fc\u3092\u878d\u5408\u3057\u305f\u30a2\u30c6\u30ed\u30fc\u30e0\u8840\u6813\u75c7\u306e\u767a\u75c7\u6a5f\u5e8f\u306e\u89e3\u660e<\/li>\n
                    2. \u4f50\u85e4\u52c7\u4e00\u90ce\uff1a\u79d1\u7814\u8cbb\u57fa\u76e4\u7814\u7a76C \u00a0\u30a2\u30c6\u30ed\u30fc\u30e0\u8840\u6813\u75c7\u306b\u304a\u3051\u308bKalirin\u306e\u95a2\u4e0e<\/li>\n
                    3. \u5c71\u4e0b\u3000\u7be4\uff1a\u79d1\u7814\u8cbb\u57fa\u76e4\u7814\u7a76C \u00a0\u52d5\u8108\u786c\u5316\u6027\u8840\u6813\u75c7\u306b\u304a\u3051\u308b\u5185\u56e0\u7cfb\u51dd\u56fa\u56e0\u5b50\u306e\u95a2\u4e0e<\/li>\n
                    4. \u9ed2\u5ca9\u9756\u6df3\uff1a\u79d1\u7814\u8cbb\u57fa\u76e4\u7814\u7a76C \u00a0\u52d5\u8108\u786c\u5316\u5de3\u306e\u8840\u6813\u6027\u30ea\u30b9\u30af\u3092\u53cd\u6620\u3059\u308b\u975e\u4fb5\u8972\u7684\u753b\u50cf\u8a3a\u65ad\u306e\u958b\u767a<\/li>\n
                    5. \u53e4\u5c0f\u8def\u82f1\u4e8c\uff1a\u79d1\u7814\u8cbb\u57fa\u76e4\u7814\u7a76C \u00a0\u5c40\u6240\u86cb\u767d\u904e\u5270\u767a\u73fe\u306b\u3088\u308b\u6df1\u90e8\u9759\u8108\u8840\u6813\u75c7\u306e\u5f62\u6210\u6a5f\u5e8f\u89e3\u6790\u3068\u6cbb\u7642\u6cd5\u306e\u78ba\u7acb<\/li>\n
                    6. \u5c71\u4e0b\u3000\u7be4\uff1a\u6771\u5317\u5927\u5b66\u52a0\u9f62\u533b\u5b66\u7814\u7a76\u6240\u3000\u5e73\u621028\u5e74\u5ea6\u6771\u5317\u5927\u5b66\u52a0\u9f62\u533b\u5b66\u7814\u7a76\u6240\u5171\u540c\u7814\u7a76\u3000\u30c8\u30ea\u30d7\u30c8\u30d5\u30a1\u30f3\u4e2d\u9593\u4ee3\u8b1d\u7523\u7269\u306e\u52d5\u8108\u786c\u5316\u30fb\u8840\u6813\u5f62\u6210\u306b\u304a\u3051\u308b\u5f79\u5272<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

                      \u539f\u8457\u8ad6\u6587 Onishi J, Sato Y, Sawaguchi A, Yamashita A, Maekawa K, Sameshima H, Asada Y. Stratified mucin-producing i … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":96,"featured_media":0,"parent":17,"menu_order":-11,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_mi_skip_tracking":false},"_links":{"self":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/45"}],"collection":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/users\/96"}],"replies":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/comments?post=45"}],"version-history":[{"count":4,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/45\/revisions"}],"predecessor-version":[{"id":595,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/45\/revisions\/595"}],"up":[{"embeddable":true,"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/pages\/17"}],"wp:attachment":[{"href":"http:\/\/www.med.miyazaki-u.ac.jp\/home\/pathophysiology\/wp-json\/wp\/v2\/media?parent=45"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}